Massachusetts Financial Services CO Harmony Biosciences Holdings, Inc. Transaction History

Massachusetts Financial Services CO

$320 Billion
Q3 2024

A detailed history of Massachusetts Financial Services CO transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 660,391 shares of HRMY stock, worth $21.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

660,391

Previous 519,701 27.07%

Holding current value

$21.9 Million

Previous $15.7 Million 68.26%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$30.0 - $39.95 $4.22 Million - $5.62 Million	140,690 Added 27.07%	660,391 $26.4 Million
Q2 2024 Aug 09, 2024	BUY	$28.81 - $33.01 $390,289 - $447,186	13,547 Added 2.68%	519,701 $15.7 Million
Q1 2024 May 14, 2024	SELL	$29.93 - $35.06 $74,166 - $86,878	-2,478 Reduced 0.49%	506,154 $17 Million
Q4 2023 Feb 08, 2024	BUY	$19.2 - $33.78 $8,332 - $14,660	434 Added 0.09%	508,632 $16.4 Million
Q3 2023 Nov 08, 2023	BUY	$31.89 - $39.03 $27,552 - $33,721	864 Added 0.17%	508,198 $16.7 Million
Q2 2023 Aug 09, 2023	BUY	$30.5 - $37.4 $2.94 Million - $3.61 Million	96,397 Added 23.46%	507,334 $17.9 Million
Q1 2023 May 10, 2023	BUY	$30.8 - $53.92 $2.18 Million - $3.82 Million	70,834 Added 20.83%	410,937 $13.4 Million
Q4 2022 Feb 13, 2023	SELL	$45.4 - $60.91 $3.42 Million - $4.59 Million	-75,348 Reduced 18.14%	340,103 $18.7 Million
Q3 2022 Nov 09, 2022	BUY	$42.06 - $55.45 $1.2 Million - $1.58 Million	28,539 Added 7.38%	415,451 $18.4 Million
Q2 2022 Aug 09, 2022	SELL	$33.54 - $52.15 $95,521 - $148,523	-2,848 Reduced 0.73%	386,912 $18.9 Million
Q1 2022 May 11, 2022	SELL	$33.14 - $51.13 $5.64 Million - $8.7 Million	-170,108 Reduced 30.38%	389,760 $19 Million
Q4 2021 Feb 10, 2022	SELL	$34.09 - $43.91 $3.68 Million - $4.74 Million	-107,916 Reduced 16.16%	559,868 $23.9 Million
Q3 2021 Nov 10, 2021	SELL	$25.68 - $38.61 $226,908 - $341,157	-8,836 Reduced 1.31%	667,784 $25.6 Million
Q2 2021 Aug 13, 2021	BUY	$25.96 - $33.44 $1.86 Million - $2.4 Million	71,755 Added 11.86%	676,620 $19.1 Million
Q1 2021 May 13, 2021	BUY	$27.56 - $40.37 $2.52 Million - $3.69 Million	91,295 Added 17.78%	604,865 $20 Million
Q4 2020 Feb 12, 2021	BUY	$31.74 - $51.34 $5.84 Million - $9.44 Million	183,902 Added 55.78%	513,570 $18.6 Million
Q3 2020 Nov 12, 2020	BUY	$30.96 - $44.39 $10.2 Million - $14.6 Million	329,668 New	329,668 $11.2 Million

Others Institutions Holding HRMY

# of Institutions

242

Shares Held

45.2M

Call Options Held

108K

Put Options Held

49.2K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $1.97B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Harmony Biosciences Holdings, Inc. Transaction History